The global leukemia therapeutics treatment market is expected to grow at a CAGR of 6.6% during the forecast period (2025–2035). Factors such as the rising prevalence of leukemia, increasing adoption ...

Taiho is parting with $400 million upfront for Araris, a spin-off from the Paul-Scherrer-Institute in Zurich, Switzerland, ...

The Japanese pharma company – currently in the process of rolling out new amyloid-targeting Alzheimer's therapy Leqembi ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

The global generic pharmaceuticals contract manufacturing market is on an upward trajectory, with a CAGR of 6.15% from 2025 to 2033. As the industry shifts towards more cost-effective and high-quality ...